Clinical Trials Directory

Trials / Completed

CompletedNCT06182995

Anticipating Decline and Providing Therapy

Anticipating Decline and Providing Therapy (ADAPT): Post-ICU Cognitive Screening Pilot and Feasibility Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
109 (actual)
Sponsor
Wake Forest University Health Sciences · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

This pilot feasibility study will be a randomized control trial of usual care following Intensive Care Unit (ICU) discharge compared to the Anticipating Decline and Providing Therapy (ADAPT) screening and support intervention. The trial aims to enroll 120 older adults (age 60 or older).

Detailed description

Anticipating Decline and Providing Therapy (ADAPT) is a program designed to support the implementation of a routine post-ICU cognitive impairment screening and support intervention. The program includes a routine validated cognitive screen for high-risk older adults at 6 weeks and 6 months post-ICU discharge. Patients with a screening assessment that may be consistent with cognitive impairment or dementia will receive additional resources including a specialized care plan developed by the Sticht Center for Healthy Aging and Alzheimer's Prevention. The specialized care plan is adapted from a health system-based dementia care intervention and designed to support post-ICU cognitive concerns. It was adapted with input from geriatrics, intensive care, and outpatient primary care clinicians. Also conducted are semi-structured interviews with 22 older adult ICU survivors and 6 primary care physicians to elicit preferences and the intervention was further adapted based on these results.

Conditions

Interventions

TypeNameDescription
BEHAVIORALUsual Care post-Intensive Care Unit (ICU)routine clinic visits
BEHAVIORALAnticipating Decline and Providing Therapy (ADAPT)routine validated cognitive screen for high-risk older adults at 6 weeks and 6 months post-ICU discharge

Timeline

Start date
2024-03-08
Primary completion
2026-03-01
Completion
2026-03-01
First posted
2023-12-27
Last updated
2026-04-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06182995. Inclusion in this directory is not an endorsement.